v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   142,086      
Beginning balance at Dec. 31, 2024 $ 965,250 $ 3 $ 1,958,157 $ (100) $ (992,810)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares)   345      
Exercise of vested stock options 758   758    
Vesting of restricted stock units (in shares)   5,315      
Shares issued under bonus program (in shares)   951      
Shares issued under bonus program $ 6,898   6,898    
Shares issued under employee stock purchase plan (in shares) 500 514      
Shares issued under employee stock purchase plan $ 3,325   3,325    
Stock-based compensation 66,818   66,818    
Net loss (106,172)       (106,172)
Other comprehensive (loss) income 88     88  
Ending balance (in shares) at Sep. 30, 2025   149,211      
Ending balance at Sep. 30, 2025 936,965 $ 3 2,035,956 (12) (1,098,982)
Beginning balance (in shares) at Jun. 30, 2025   147,172      
Beginning balance at Jun. 30, 2025 942,647 $ 3 2,012,312 (169) (1,069,499)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares)   28      
Exercise of vested stock options 71   71    
Vesting of restricted stock units (in shares)   2,011      
Stock-based compensation 23,573   23,573    
Net loss (29,483)       (29,483)
Other comprehensive (loss) income 157     157  
Ending balance (in shares) at Sep. 30, 2025   149,211      
Ending balance at Sep. 30, 2025 $ 936,965 $ 3 2,035,956 (12) (1,098,982)
Beginning balance (in shares) at Dec. 31, 2025 151,500 151,537      
Beginning balance at Dec. 31, 2025 $ 929,578 $ 3 2,044,103 (41) (1,114,487)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares)   272      
Exercise of vested stock options 1,314   1,314    
Vesting of restricted stock units (in shares)   6,561      
Shares issued under bonus program (in shares)   2,180      
Shares issued under bonus program $ 39,455   39,455    
Shares issued under employee stock purchase plan (in shares) 500 497      
Shares issued under employee stock purchase plan $ 4,609   4,609    
Stock-based compensation 76,575   76,575    
Net loss (47,370)       (47,370)
Other comprehensive (loss) income $ (588)     (588)  
Ending balance (in shares) at Sep. 30, 2026 161,000 161,047      
Ending balance at Sep. 30, 2026 $ 1,003,573 $ 3 2,166,056 (629) (1,161,857)
Beginning balance (in shares) at Jun. 30, 2026   159,074      
Beginning balance at Jun. 30, 2026 990,817 $ 3 2,141,909 (493) (1,150,602)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares)   17      
Exercise of vested stock options 179   179    
Vesting of restricted stock units (in shares)   1,956      
Stock-based compensation 23,968   23,968    
Net loss (11,255)       (11,255)
Other comprehensive (loss) income $ (136)     (136)  
Ending balance (in shares) at Sep. 30, 2026 161,000 161,047      
Ending balance at Sep. 30, 2026 $ 1,003,573 $ 3 $ 2,166,056 $ (629) $ (1,161,857)